[go: up one dir, main page]

HUP0300142A2 - Humán LDL-receptorra specifikus monoklonális ellenanyagok, előállításuk és alkalmazásuk - Google Patents

Humán LDL-receptorra specifikus monoklonális ellenanyagok, előállításuk és alkalmazásuk

Info

Publication number
HUP0300142A2
HUP0300142A2 HU0300142A HUP0300142A HUP0300142A2 HU P0300142 A2 HUP0300142 A2 HU P0300142A2 HU 0300142 A HU0300142 A HU 0300142A HU P0300142 A HUP0300142 A HU P0300142A HU P0300142 A2 HUP0300142 A2 HU P0300142A2
Authority
HU
Hungary
Prior art keywords
monoclonal antibodies
production
antibodies specific
ldl receptor
human ldl
Prior art date
Application number
HU0300142A
Other languages
English (en)
Inventor
Francesco Antonetti
Ilana Belzer
Michel Dreano
Moshe Smolarsky
Dany Suissa
Nachum Yonah
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26323933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0300142(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL13502500A external-priority patent/IL135025A0/xx
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of HUP0300142A2 publication Critical patent/HUP0300142A2/hu
Publication of HUP0300142A3 publication Critical patent/HUP0300142A3/hu
Publication of HU226194B1 publication Critical patent/HU226194B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A találmány tárgyát alacsony sűrűségű lipoproteinek humán receptorait(LDLR) specifikusan felismerni képes monoklonális ellenanyagokképezik. Ezeket az ellenanyagokat például humán, szolubilis LDLR(hsLDL) azonosítására és tisztítására lehet alkalmazni termelésieljárásokban, valamint betegségek, például hepatitisz-C-fertőzés (HCV)azonosítására és kezelésére. A találmány tárgyát képezik továbbá atalálmány szerinti monoklonális ellenanyagokat termelő hibridómák,valamint a találmány szerinti ellenanyagok alkalmazásai és előállításieljárásai. Ó
HU0300142A 2000-03-13 2001-03-08 Humán szolubilis LDL-receptorra specifikus monoklonális ellenanyagok, elõállításuk és alkalmazásuk HU226194B1 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL13502500A IL135025A0 (en) 2000-03-13 2000-03-13 Monoclonal antibodies to the human ldl receptor, their production and use
IL13921700A IL139217A0 (en) 2000-03-13 2000-10-23 Monoclonal antibodies to the human ldl receptor, their production and use
PCT/IL2001/000216 WO2001068710A1 (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human ldl receptor, their production and use

Publications (3)

Publication Number Publication Date
HUP0300142A2 true HUP0300142A2 (hu) 2003-06-28
HUP0300142A3 HUP0300142A3 (en) 2005-07-28
HU226194B1 HU226194B1 (hu) 2008-06-30

Family

ID=26323933

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300142A HU226194B1 (hu) 2000-03-13 2001-03-08 Humán szolubilis LDL-receptorra specifikus monoklonális ellenanyagok, elõállításuk és alkalmazásuk

Country Status (33)

Country Link
US (1) US6849720B2 (hu)
EP (1) EP1263790B1 (hu)
JP (1) JP4768193B2 (hu)
KR (1) KR100882081B1 (hu)
CN (1) CN1418225B (hu)
AR (1) AR028518A1 (hu)
AT (1) ATE362490T1 (hu)
AU (2) AU4100201A (hu)
BG (1) BG65762B1 (hu)
BR (1) BR0109164A (hu)
CA (1) CA2402593C (hu)
CY (1) CY1108020T1 (hu)
CZ (1) CZ20023098A3 (hu)
DE (1) DE60128452T2 (hu)
DK (1) DK1263790T3 (hu)
EA (1) EA007494B1 (hu)
EE (1) EE200200517A (hu)
ES (1) ES2282238T3 (hu)
HK (1) HK1055750A1 (hu)
HR (1) HRP20020704B1 (hu)
HU (1) HU226194B1 (hu)
IL (2) IL139217A0 (hu)
MX (1) MXPA02009091A (hu)
NO (1) NO330904B1 (hu)
NZ (1) NZ520944A (hu)
PL (1) PL206041B1 (hu)
PT (1) PT1263790E (hu)
RS (1) RS51406B (hu)
SI (1) SI1263790T1 (hu)
SK (1) SK287348B6 (hu)
UA (1) UA78489C2 (hu)
WO (1) WO2001068710A1 (hu)
ZA (1) ZA200206654B (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114629D0 (en) * 2001-06-15 2001-08-08 Pfizer Ltd Method
ES2401645T3 (es) 2003-06-19 2013-04-23 Merck Serono Sa Uso de agentes moduladores de la conversión de priones
FR2889532B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
FR2889533B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
JP2009526991A (ja) * 2006-02-17 2009-07-23 パオロ・ラ・コッラ 増殖性疾患及び／又はコンホメーション病の診断方法
FR2910896B1 (fr) * 2006-12-29 2012-11-16 Lab Francais Du Fractionnement Anticorps monoclonal dirige contre le recepteur humain des ldl
IL182956A0 (en) 2007-05-03 2008-01-20 Yeda Res & Dev Glycan modified soluble receptors and binding proteins and their use
IL188628A0 (en) * 2008-01-07 2008-12-29 Yeda Res & Dev Use of soluble ldl-r for viral hepatitis
GB0922377D0 (en) * 2009-12-22 2010-02-03 Arab Gulf University The Mutant LDL receptor
CN103429265A (zh) 2010-05-25 2013-12-04 国家医疗保健研究所 用于治疗和预防hcv感染的抗包膜抗体和抗受体抗体组合物
WO2013024156A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
WO2013024157A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of host targeting agents for the treatment and the prevention of hcv infection
WO2013024155A1 (en) 2011-08-17 2013-02-21 Inserm (Institut National De La Sante Et De La Recherche Medicale) Combinations of anti-hcv-entry factor antibodies and direct acting antivirals for the treatment and the prevention of hcv infection
CN103111270B (zh) * 2013-02-26 2015-06-10 王业富 一种乙型肝炎抗原蛋白的吸附材料及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182364A (en) * 1990-02-26 1993-01-26 The Scripps Research Institute Polypeptide analogs of apolipoprotein E
US5496926A (en) * 1992-01-19 1996-03-05 Yeda Research And Development Co. Ltd. Process of preparing a soluble LDL receptor
US5945308A (en) * 1998-04-03 1999-08-31 Incyte Pharmaceuticals, Inc. Human oxidized LDL receptor
JP2000279174A (ja) * 1999-03-30 2000-10-10 Bml Inc ヒトｌｄｌレセプターに対するモノクローナル抗体及びこれを用いる家族性高脂血症の判定方法

Also Published As

Publication number Publication date
DE60128452T2 (de) 2007-09-13
BG107063A (bg) 2003-05-30
ZA200206654B (en) 2003-10-20
AR028518A1 (es) 2003-05-14
CA2402593C (en) 2012-07-03
AU2001241002B8 (en) 2006-05-04
EP1263790A1 (en) 2002-12-11
PL206041B1 (pl) 2010-06-30
SI1263790T1 (sl) 2007-10-31
HU226194B1 (hu) 2008-06-30
US6849720B2 (en) 2005-02-01
ES2282238T3 (es) 2007-10-16
HRP20020704B1 (en) 2011-01-31
CZ20023098A3 (cs) 2003-02-12
AU2001241002B2 (en) 2006-04-06
JP2004506603A (ja) 2004-03-04
CN1418225A (zh) 2003-05-14
NO20024223L (no) 2002-10-24
PT1263790E (pt) 2007-06-01
WO2001068710A1 (en) 2001-09-20
HK1055750A1 (en) 2004-01-21
YU68602A (sh) 2006-03-03
MXPA02009091A (es) 2005-06-20
NO330904B1 (no) 2011-08-15
BG65762B1 (bg) 2009-10-30
RS51406B (sr) 2011-02-28
PL358381A1 (en) 2004-08-09
BR0109164A (pt) 2002-11-26
KR100882081B1 (ko) 2009-02-10
DK1263790T3 (da) 2007-07-02
NZ520944A (en) 2004-04-30
NO20024223D0 (no) 2002-09-04
AU4100201A (en) 2001-09-24
JP4768193B2 (ja) 2011-09-07
SK287348B6 (sk) 2010-08-09
CA2402593A1 (en) 2001-09-20
EE200200517A (et) 2004-02-16
IL151713A0 (en) 2003-04-10
SK13122002A3 (sk) 2003-04-01
US20030186343A1 (en) 2003-10-02
HUP0300142A3 (en) 2005-07-28
HRP20020704A2 (en) 2004-12-31
DE60128452D1 (de) 2007-06-28
KR20020089384A (ko) 2002-11-29
EA007494B1 (ru) 2006-10-27
CY1108020T1 (el) 2013-09-04
UA78489C2 (en) 2007-04-10
CN1418225B (zh) 2012-04-18
ATE362490T1 (de) 2007-06-15
IL139217A0 (en) 2001-11-25
EA200200974A1 (ru) 2003-02-27
EP1263790B1 (en) 2007-05-16

Similar Documents

Publication Publication Date Title
HUP0300142A2 (hu) Humán LDL-receptorra specifikus monoklonális ellenanyagok, előállításuk és alkalmazásuk
NO20030845D0 (no) Utvalgte fusjonerte pyrrolokarbazoler
NO20063193L (no) Fusjonerte pyrrolokarbazoler og fremgangsmater for fremstilling derav
TR200300478T2 (tr) Hümanize antiLT-ß-R antikorları
DE69927960D1 (de) Epiallopregnanolon zur behandlung von krankheiten des cns
EA200501286A1 (ru) МОЛЕКУЛЫ АНТИТЕЛ СО СПЕЦИФИЧНОСТЬЮ К ЧЕЛОВЕЧЕСКОМУ IL-1β
NO20063196L (no) Nye fusjonerte pyrrolokarbazoler
TW200500377A (en) Method of humanizing immune system molecules
HUP9904620A2 (hu) Tisztított spermiumfelületi antigén,annak megfelelő monoklonális ellenanyag és alkalmazási területeik
DK0552296T3 (da) Monoklonale antistoffer fra mus
EA200401081A1 (ru) Fab-фрагменты моноклонального антитела человека, направленные против гликопротеина e2 hcv и обладающие нейтрализующей активностью in vitro
DK0461177T3 (da) Humant intra-acrosomalt spermantigen til anvendelse i en svangerskabsforebyggende vaccine
DE60121545D1 (de) Virus des porzinen reproduktiven und respiratorischen syndroms und dessen verwendung
NO20055741D0 (no) Nye kjemiske forbindelser
DE50009240D1 (de) Verwendung von Antikörpern zur Vakzinierung gegen Krebs
EA200701092A1 (ru) Антигенные эпитопы интерлейкина-21, связанные с ними антитела и их применение в медицине
ATE206621T1 (de) Il-8 antagonisten zur behandlung von asthma
ATE370160T1 (de) Peptide mit affinität zu gp120, und ihre verwendungen
DK1374895T3 (da) Farmaceutisk sammensætning af F(AB) 2-fragmenter af antistoffer og fremgangsmåde til fremstilling heraf
ES2195033T3 (es) Iso-indolonas condensadas utilizadas como inhibidores de proteina quinasa c.
EP1320351A4 (en) METHODS OF PREPARING IMMUNOGLOBULIN AND ITS USE
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
DE60229624D1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion
HUP0301085A2 (hu) Új peptid és alkalmazása szelektálási eljárásra
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees